Plain-English translation of NCT07357636 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study follows people with solid tumors who are starting immune checkpoint inhibitor therapy — a type of cancer treatment that helps your immune system fight cancer. The study aims to predict and better understand immune-related side effects (unwanted reactions caused by the treatment activating your immune system) by collecting blood samples, medical information, and imaging over time. Researchers hope to identify early warning signs so doctors can catch and manage these side effects before they become serious.
While this medication has helped many cancer patients, it can sometimes trigger the immune system to attack healthy parts of the body, causing side effects that affect different organs. These side effects are often unpredictable and can be serious, especially when they affect the brain or multiple organ systems. This study exists to figure out who is most likely to experience these problems and how to spot them early so they can be managed better.
You likely qualify if…
You likely don't qualify if…
You would start the study before your first dose of immunotherapy treatment and provide baseline blood samples and medical information. After treatment begins, you would have regular check-in visits at planned intervals where researchers collect more blood samples, review your health, and ask about any side effects you're experiencing. If you develop a significant immune-related side effect, you may have additional visits and tests. The study tracks you over time to build a detailed picture of what happens during and after your treatment.
AI-generated summary from trial data · Oct 11, 2026 · Not medical advice
China